Drug resistance modulation in the laboratory and the clinic
Dalton, W.S.
Seminars in Oncology 20(1): 64-69
1993
ISSN/ISBN: 0093-7754 PMID: 8475411 Document Number: 417177
Document emailed within 1 workday
Related Documents
Pillay, D.; Schinazi, R.F. 1998: Antiviral drug resistance: from the laboratory to the patient Antiviral Therapy 3(4): 237Bobkova, M.R. 2002: HIV drug resistance and laboratory methods for its detection (Lecture) Klinicheskaia Laboratornaia Diagnostika 2002(1): 25-32
Weisenthal, L.M.; Dill, P.L.; Finklestein, J.Z.; Duarte, T.E.; Baker, J.A.; Moran, E.M. 1986: Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms Cancer Treatment Reports 70(11): 1283-1295
Hassan, A.S.; Mwaringa, S.M.; Obonyo, C.A.; Nabwera, H.M.; Sanders, E.J.; Rinke de Wit, T.F.; Cane, P.A.; Berkley, J.A. 2013: Low prevalence of transmitted HIV type 1 drug resistance among antiretroviral-naive adults in a rural HIV clinic in Kenya Aids Research and Human Retroviruses 29(1): 129-135
Reid, G.; Seidenfeld, A. 1997: Drug resistance amongst uropathogens isolated from women in a suburban population: laboratory findings over 7 years Canadian Journal of Urology 4(4): 432-437
Aghokeng, A.F.; Vergne, L.; Mpoudi-Ngole, E.; Mbangue, M.; Deoudje, N.; Mokondji, E.; Nambei, W.S.; Peyou-Ndi, M.M.; Moka, J.-J.L.; Delaporte, E.; Peeters, M. 2009: Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries Antiviral Therapy 14(3): 401-411
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836
Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317
Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035
Pryce, A. 2001: `The first thing i Did when i Came Back from the Clinic Last Week Was Change the Sheets on the Bed': Contamination, Penetration and Resistance - Male Clients in the VD Clinic Current Sociology 49(3): 55-78
Bertagnolio, S.; Rodriguez-Diaz, R.A.; Fuentes-Romero, L.L.; Bennett, D.E.; Viveros-Rogel, M.; Hart, S.; Pilon, R.; Sandstrom, P.; Soto-Ramirez, L.E. 2012: Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S328-S333
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Ahmad, S.; Trepel, J.B.; Ohno, S.; Suzuki, K.; Tsuruo, T.; Glazer, R.I. 1992: Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin Molecular Pharmacology 42(6): 1004-1009
Kahán, Z.; Thurzó, L.ás.ó 2005: Hormone resistance and its modulation in breast cancer Orvosi Hetilap 146(16): 731-737
Wang, F. 2006: To enhance the research of antibiotic resistance and infection caused by drug-resistance bacteria Zhonghua Yi Xue Za Zhi 86(9): 579-580
Harada, Y.; Kitahara, Y.; Ninomiya, H.; Harada, S.; Takamoto, M.; Ishibashi, T. 1994: A study on drug resistance of newly admitted pulmonary tuberculosis patients with special reference to the resistance to SM, INH, EB and RFP Kekkaku: 69(12): 751-757
Rabinovich, S.A. 1976: Drug resistance in malaria parasites. 1. The nature of resistance, its distribution and epidemiological implications (review of the literature) Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(4): 464-477
Li, J.; Ma, Y.-x.; Zhang, Q.-b.; Zhou, Y.-a.; Shang, R.-p.; Li, P.-l.; Hao, Z.-q. 2013: Correlations of integrons and resistance gene cassettes in Gram-negative bacteria with multi-drug resistance Zhonghua Yi Xue Za Zhi 93(46): 3698-3702
Danks, M.K.; Yalowich, J.C.; Beck, W.T. 1987: Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26) Cancer Research 47(5): 1297-1301
Baba, H. 1994: Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin Kekkaku: 69(6): 387-396